ATHX Up Following Positive Results For Multistem

Athersys Inc

shares gained close to 4% on Monday, after the company reported that a study has demonstrated that its stem cell therapy product, Multistem, is able to reduce brain damage in animals following a traumatic brain injury. The next issue of the journal, Experimental Neurology, will publish the study. ATHX jumped 3.70% to $3.36 at 10:54 am. Shares of Athersys have gained 8.36% over the past month and have declined 21.55% so far this year. Read more